OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. McDonald on the Next Step for Angiogenesis Inhibitors

September 13th 2011

Dr. Donald McDonald from the UCSF Comprehensive Cancer Center on the Next Step for Angiogenesis Inhibitors

Dr. Yoneda Discusses Integrating the Pulmonologist

September 12th 2011

Dr.Ken Yoneda from UC Davis Cancer Center Discusses Integrating the Pulmonologist into Multidisciplinary Practice

Dr. Bradley Discusses Key Lung Cancer Topics

September 12th 2011

Dr. Jeffrey Bradley from Washington University School of Medicine Discusses Key Lung Cancer Topics

Dr. Tripathy Discusses Biomarker Use in Clinical Trials

September 12th 2011

Dr. Debu Tripathy from the USC Norris Comprehensive Cancer Center Discusses Biomarker Use in Clinical Trials

Dr. Rugo on the Future of Angiogenesis in Breast Cancer

September 9th 2011

Dr. Hope S. Rugo from UCSF Cancer Center on the Future of Angiogenesis in Breast Cancer

Dr. Li Discusses the EML4-ALK Fusion Gene

September 9th 2011

Dr. Tianhong Li from UC Davis Cancer Center Discusses the EML4-ALK Fusion Gene

Dr. O'Shaughnessy on the Future of Breast Cancer

September 9th 2011

Dr. Joyce A. O'Shaughnessy from Baylor Sammons Cancer Center on the Future of Breast Cancer Treatment

Dr. McDonald on Resistance to Angiogenesis Inhibitors

September 8th 2011

Dr. Donald M. McDonald from the UCSF Cancer Center Discusses Resistance to Angiogenesis Inhibitors

Dr. Scagliotti Discusses the Future of Lung Cancer Therapy

September 8th 2011

Dr. Giorgio V. Scagliotti from the University of Turin Discusses the Future of Lung Cancer Therapy

Dr. Dixon on Advances in Axillary Node Procedures

September 8th 2011

Dr. J. Michael Dixon from the University of Edinburgh on Advances in Breast Cancer Axillary Node Procedures

Dr. Rugo on Anti-Angiogenesis Therapy Response Predictors

September 7th 2011

Dr. Hope S. Rugo from University of California, San Francisco on Anti-Angiogenesis Therapy Response Predictors

Dr. Dixon Discusses Advances in Breast Cancer Treatment

September 6th 2011

Dr. J. Michael Dixon from the University of Edinburgh Discusses Advances in Breast Cancer Treatment

Dr. Baas on the Standard of Care for Mesothelioma Patients

September 6th 2011

Dr. Paul Baas from the Netherlands Cancer Institute on the Standard of Care for Mesothelioma Patients

Dr. Ellis on Measuring Endocrine Therapy Efficacy

September 6th 2011

Dr. Matthew J. Ellis from Washington University on Measuring Endocrine Therapy Efficacy With Ki67

Dr. Yoneda Describes the Clinical Care Pulmonologist

September 2nd 2011

Dr. Ken Yoneda from the UC Davis Cancer Center Describes the Clinical Care Pulmonologist

Dr. Li Discusses the PROFILE Crizotinib Clinical Trials

September 1st 2011

Dr. Tianhong Li from UC Davis Cancer Center Discusses the PROFILE Crizotinib Clinical Trials

Dr. Tripathy on Connecting Markers to Clinical Outcomes

September 1st 2011

Dr. Debu Tripathy from the USC Norris Cancer Center on Connecting Markers to Clinical Outcomes

Dr. Scagliotti on Personalizing Care With Pemetrexed

August 31st 2011

Dr. Giorgio V. Scagliotti from the University of Turin Discusses Personalizing Care With Pemetrexed

Dr. Ellis on Ki67 as Treatment Monitoring Biomarkers

August 31st 2011

Dr. Matthew J. Ellis from Washington University Discusses Ki67 as a Treatment Monitoring Biomarker

Dr. O'Shaughnessy on Breast Cancer Biomarkers

August 30th 2011

Dr. Joyce A. O'Shaughnessy from Baylor Sammons Cancer Center on the Future of Breast Cancer Biomarkers